cerdulatinib
Showing 1 - 3 of 3
Relapsed/Refractory Chronic Lymphocytic Leukemia, Non-hodgkin's Lymphoma Trial (cerdulatinib)
Available
- Relapsed/Refractory Chronic Lymphocytic Leukemia
- Non-hodgkin's Lymphoma
- cerdulatinib
- (no location specified)
May 6, 2022
Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma
Completed
- Follicular Lymphoma (FL/Indolent NHL)
- +4 more
- Cerdulatinib
- Rituximab
-
Huntsville, Alabama
- +22 more
Apr 1, 2022
Peripheral T-Cell Lymphoma (PTCL NOS), Nodal Lymphomas of T Follicular Helper (TFH), Follicular T-cell Lymphoma (FTCL) Trial
Withdrawn
- Peripheral T-Cell Lymphoma (PTCL NOS)
- +8 more
- Cerdulatinib
- (no location specified)
Mar 10, 2020